BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37894295)

  • 1. Colorectal Cancer Is Borrowing Blueprints from Intestinal Ontogenesis.
    Billingsley JL; Yevdokimova V; Ayoub K; Benoit YD
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 knockout decreases stemness properties in colorectal cancer cells.
    Avendaño-Felix M; Aguilar-Medina M; Romero-Quintana JG; Ayala-Ham A; Beltran AS; Olivares-Quintero JF; López-Camarillo C; Pérez-Plasencia C; Bermúdez M; Lizárraga-Verdugo E; López-Gutierrez J; Sanchez-Schmitz G; Ramos-Payán R
    J Gastrointest Oncol; 2023 Aug; 14(4):1735-1745. PubMed ID: 37720443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Bergin CJ; Zouggar A; Haebe JR; Masibag AN; Desrochers FM; Reilley SY; Agrawal G; Benoit YD
    Oncogene; 2021 Feb; 40(6):1191-1202. PubMed ID: 33323965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
    Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
    Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microRNAs in the regulation of cancer stem cells.
    Takahashi RU; Miyazaki H; Ochiya T
    Front Genet; 2014 Jan; 4():295. PubMed ID: 24427168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.
    Eini L; Naseri M; Karimi-Busheri F; Bozorgmehr M; Ghods R; Madjd Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4101-4116. PubMed ID: 36040667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of breast cancer stem cell features.
    Czerwinska P; Kaminska B
    Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.
    Carrasco-Garcia E; Lopez L; Aldaz P; Arevalo S; Aldaregia J; Egaña L; Bujanda L; Cheung M; Sampron N; Garcia I; Matheu A
    Sci Rep; 2016 Aug; 6():32350. PubMed ID: 27571710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
    Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
    Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
    Chanmee T; Ontong P; Kimata K; Itano N
    Front Oncol; 2015; 5():180. PubMed ID: 26322272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation.
    Bala P; Rennhack JP; Aitymbayev D; Morris C; Moyer SM; Duronio GN; Doan P; Li Z; Liang X; Hornick JL; Yurgelun MB; Hahn WC; Sethi NS
    Sci Adv; 2023 Mar; 9(13):eadf0927. PubMed ID: 36989360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells.
    Naik PP; Panigrahi S; Parida R; Praharaj PP; Bhol CS; Patil S; Manjunath N; Ghosh D; Patra SK; Bhutia SK
    Stem Cell Rev Rep; 2022 Jan; 18(1):198-213. PubMed ID: 34355273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
    Schaefer T; Steiner R; Lengerke C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
    Liang X; Duronio GN; Yang Y; Bala P; Hebbar P; Spisak S; Sahgal P; Singh H; Zhang Y; Xie Y; Cejas P; Long HW; Bass AJ; Sethi NS
    Gastroenterology; 2022 Jan; 162(1):209-222. PubMed ID: 34571027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
    Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.